DavidJVaughnMD
Oncology • Philadelphia, PAGenitourinary Oncology, Hematologic Oncology
Professor of Medicine, University Pennsylvania
Dr. Vaughn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Civic Center Blvd
Fl 23
Philadelphia, PA 19104Phone+1 800-789-7366- Is this information wrong?
Summary
- Dr. David Vaughn is an oncologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center. He received his medical degree from Harvard Medical School and has been in practice 30 years. He specializes in genitourinary oncology and hematologic oncology and is experienced in hematologic oncology, prostate cancer, urologic oncology, bladder cancer, and testicular cancer.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1990 - 1993
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1987 - 1990
Harvard Medical SchoolClass of 1987
Certifications & Licensure
NJ State Medical License 2021 - 2025
PA State Medical License 1990 - 2024- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACP) American College of Physicians, 2005
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.Jakob Lauritsen, Nicolas Sauvé, Alexey Tryakin, Di Maria Jiang, Robert Huddart, Daniel Y C Heng, Angelika Terbuch, Eric Winquist, Michal Chovanec, Marcus Hentrich, Chr...> ;British Journal of Cancer. 2023 Nov 1
- 2 citationsGermline Exome Sequencing for Men with Testicular Germ Cell Tumor Reveals Coding Defects in Chromosomal Segregation and Protein-targeting Genes.Louise C Pyle, Jung Kim, Jonathan Bradfield, Scott M Damrauer, Kurt D'Andrea, Lawrence H Einhorn, Rama Godse, Hakon Hakonarson, Peter A Kanetsky, Rachel L Kember, Lind...> ;European Urology. 2024 Apr 1
- 4 citationsCancer Control, Toxicity, and Secondary Malignancy Risks of Proton Radiation Therapy for Stage I-IIB Testicular Seminoma.Russell Maxwell, Yushi Chang, Christina Paul, David J Vaughn, John P Christodouleas> ;Advances in Radiation Oncology. 2023 May 2
- Join now to see all
Other
- Approach to the care of long-term testicular cancer survivorsVaughn DJ, Beard CJ
http://www.uptodate.com/contents/approach-to-the-care-of-long-term-testicular-cancer-survivors
UpToDate, Wolters Kluwer Health - 2012-07-10
Press Mentions
Pembrolizumab Offers Better QOL vs Chemo in Advanced Urothelial CancerApril 9th, 2018
1 in 4 Inmate Deaths Happens in the Same Federal Prison. Why?September 28th, 2023
Committees
- Chair, ABIM Medical Oncology SEP 2013 - 2014
Professional Memberships
- Fellow
- Member
Hospital Affiliations
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania- Penn Presbyterian Medical CenterPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
